Impacto de un programa de validación transversal en atención farmacéutica al paciente con insuficiencia renal

• Autores: Marta Gallego Úbeda, Federico Tutau Gómez, Laura Delgado Téllez, María Angeles Campos Fernández de Sevilla
• Localización: Atención Farmacéutica, ISSN 1139-7357, Vol. 13, Nº. 5, 2011, págs. 257-270
• Idioma: español
• Títulos paralelos:
  • Impact of a cross-sectional validation program on pharmaceutical care for the kidney failure patient
• Texto completo no disponible (Saber más ...)
• Resumen

  • Objective: Description of pharmaceutical interventions performed on patients with kidney failure (KF) according to the cross-sectional validation (CV) methodology, and by means of a new computer software tool. Method: 7-month observational study in hospitalization and emergency services. We proposed CV as a complement to the traditional pharmacotherapeutic validation. For such a purpose, we designed a software tool that: 1. Integrates the hospital's computer systems; 2. Reports those patients with ClCr (Creatinine Clearance) <60 ml/min/1.73 m 2 and drugs that require a recommendation on KF; and 3. Sends those recommendations to the physician. Results: 2,535 patients showed a ClCr < 60 ml/min/1.73 m 2, 806 of them also had some drugs that required recommendation on KF. 295 interventions were performed: 48% accepted and 19% rejected (the remaining were classified as "not applicable"). The active principle and department with the most interventions were respectively levofloxacin and the Emergency Department. A pharmacist performed, on an average time of 26.7 minutes/day, the CV of the KF DRP (Drug Related Problem) in all patients. Conclusions: CV increases the efficiency in detecting and resolving DRPs, allows for an early detection in the Emergency Department and helps in the decision-making process